SU-E-T-798: Verification of 3DVH Dose Distribution Before Clinical Implementation for Patient-Specific IMRT QA
- CARTI, Inc., Little Rock, AR (United States)
Purpose: In recent years patient-specific IMRT QA has transitioned from film and chamber measurements to beam-by-beam 2D array measurements. 3DVH takes this transition a step further by estimating the 3D dose distribution delivered using 2D per beam diode array measurements. In this study, the 3D dose distribution generated by 3DVH is compared to film and chamber measurements. In addition, the accuracy ROI volume and error detection is investigated. Methods: Composite film and ion chamber measurements in a solid water phantom were performed for 9 IMRT PINNACLE patient plans for 4 treatment sites. The film and chamber measurements were compared to the dose distribution predicted by 3DVH using MAPCHECK2 per beam measurements. The absolute point dose measurement (CAX) was extracted from the predicted 3DVH and PINNACLE dose distribution and was compared by taking the ratio of measured to predicted doses. The dose distribution measured with film was compared to the distribution in the corresponding plane (AX, SAG, COR) extracted from predicted dose distribution by 3DVH and PINNACLE using a 2D gamma analysis. Gamma analysis was performed with 2% dose, 2 mm DTA, 20% threshold, and global normalization. In addition, the percent difference between 3DVH and PINNACLE ROI volumes was calculated. Results: The average ratio of the measured point dose vs the 3DVH predicted dose was 1.017 (σ=0.011). The average gamma passing rate for measured vs 3DVH dose distributions was 95.1% (σ=2.53%). The average percent difference of 3DVH vs PINNACLE ROI volume was 2.29% (σ=2.5%). Conclusion: The dose distributions predicted by 3DVH using MAPCHECK2 measurements are the same as the distributions that would have been obtained using film and chamber. The ROI volumes used in 3DVH are not an exact match to those in PINNACLE; the effect requires more investigation. The accuracy of error detection by 3DVH is currently being investigated.
- OSTI ID:
- 22555163
- Journal Information:
- Medical Physics, Vol. 42, Issue 6; Other Information: (c) 2015 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-2405
- Country of Publication:
- United States
- Language:
- English
Similar Records
SU-F-T-238: Analyzing the Performance of MapCHECK2 and Delta4 Quality Assurance Phantoms in IMRT and VMAT Plans
SU-E-T-789: Validation of 3DVH Accuracy On Quantifying Delivery Errors Based On Clinical Relevant DVH Metrics